Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."

"The executive order I'm signing, we're actually signing the executive order today, is really a moment," Trump said. "These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients."